Learn More
This study compares two cytotoxic regimens comprising the same dose and schedule of cisplatin (CP) plus vinorelbine (VNR) or gemcitabine (GEM) administered under the same schedule to patients with(More)
10588 Background: 18F-FDG-PET is rapidly spreading "technology" in oncology. Its appropriate use and the clinical settings in which it can modify decision-making need to be defined. METHODS All the(More)